New insights into a microvascular invasion prediction model in hepatocellular carcinoma: A retrospective study from the SEER database and China
暂无分享,去创建一个
[1] Yan Zhao,et al. Computed Tomography Radiomics-Based Prediction of Microvascular Invasion in Hepatocellular Carcinoma , 2022, Frontiers in Medicine.
[2] Z. Ye,et al. Prediction of microvascular invasion in HCC by a scoring model combining Gd-EOB-DTPA MRI and biochemical indicators , 2022, European Radiology.
[3] Xi Yu,et al. Preoperative nomogram for microvascular invasion prediction based on clinical database in hepatocellular carcinoma , 2021, Scientific Reports.
[4] A. Jemal,et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.
[5] J. Zhong,et al. The clinical significance of microvascular invasion in the surgical planning and postoperative sequential treatment in hepatocellular carcinoma , 2021, Scientific Reports.
[6] Chihao Zhang,et al. Preoperative prediction of microvascular invasion in non-metastatic hepatocellular carcinoma based on nomogram analysis , 2020, Translational oncology.
[7] Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.
[8] Lin Wang,et al. Development and validation of a prediction model for microvascular invasion in hepatocellular carcinoma , 2020, World journal of gastroenterology.
[9] C. Neuzillet,et al. Immune Therapy for Liver Cancers , 2019, Cancers.
[10] Jianhong Lin,et al. Integrated Nomograms for Preoperative Prediction of Microvascular Invasion and Lymph Node Metastasis Risk in Hepatocellular Carcinoma Patients , 2019, Annals of Surgical Oncology.
[11] Zhiming Wang,et al. Nomogram For Preoperative Prediction Of Microvascular Invasion Risk In Hepatocellular Carcinoma , 2019, Cancer management and research.
[12] C. Murray,et al. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2019, The Lancet.
[13] Ming Ni,et al. Radiomics models for diagnosing microvascular invasion in hepatocellular carcinoma: which model is the best model? , 2019, Cancer Imaging.
[14] W. Lau,et al. The impact of resection margin and microvascular invasion on long-term prognosis after curative resection of hepatocellular carcinoma: a multi-institutional study. , 2019, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[15] Jing Zhang,et al. Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma. , 2019, Journal of hepatology.
[16] D. Xie,et al. Postoperative adjuvant sorafenib improves survival outcomes in hepatocellular carcinoma patients with microvascular invasion after R0 liver resection: a propensity score matching analysis. , 2019, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[17] B. Li,et al. Treatment selection of recurrent hepatocellular carcinoma with microvascular invasion at the initial hepatectomy. , 2019, American journal of translational research.
[18] W. Rong,et al. Nomogram to Assist in Surgical Plan for Hepatocellular Carcinoma: a Prediction Model for Microvascular Invasion , 2019, Journal of Gastrointestinal Surgery.
[19] K. Tanabe,et al. Prognostic and Therapeutic Implications of Microvascular Invasion in Hepatocellular Carcinoma , 2019, Annals of Surgical Oncology.
[20] D. Gu,et al. A Radiomics Nomogram for Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma , 2018, Liver Cancer.
[21] Yaming Li,et al. Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition) , 2018, Liver Cancer.
[22] S. Hyun,et al. Preoperative prediction of microvascular invasion of hepatocellular carcinoma using 18F-FDG PET/CT: a multicenter retrospective cohort study , 2018, European Journal of Nuclear Medicine and Molecular Imaging.
[23] T. Ishiko,et al. Microvascular Invasion in Small-sized Hepatocellular Carcinoma: Significance for Outcomes Following Hepatectomy and Radiofrequency Ablation. , 2018, Anticancer research.
[24] A. Jemal,et al. Disparities in liver cancer occurrence in the United States by race/ethnicity and state , 2017, CA: a cancer journal for clinicians.
[25] L. Mao,et al. Anatomical versus non‐anatomical resection for solitary hepatocellular carcinoma without macroscopic vascular invasion: A propensity score matching analysis , 2017, Journal of gastroenterology and hepatology.
[26] W. Cong,et al. Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update , 2016, World journal of gastroenterology.
[27] Kui Wang,et al. Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria. , 2016, JAMA surgery.
[28] W. Lau,et al. Postoperative Adjuvant Transcatheter Arterial Chemoembolization After R0 Hepatectomy Improves Outcomes of Patients Who have Hepatocellular Carcinoma with Microvascular Invasion , 2016, Annals of Surgical Oncology.
[29] A. Jemal,et al. Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.
[30] M. Schwartz,et al. Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. , 2015, Annals of surgery.
[31] M. Sata,et al. The Significance of Classifying Microvascular Invasion in Patients with Hepatocellular Carcinoma , 2014, Annals of Surgical Oncology.
[32] J. Bruix,et al. Hepatocellular carcinoma , 2012, The Lancet.
[33] P. Chow,et al. Microvascular Invasion Is a Better Predictor of Tumor Recurrence and Overall Survival Following Surgical Resection for Hepatocellular Carcinoma Compared to the Milan Criteria , 2011, Annals of surgery.
[34] A. Neugut,et al. Obesity and Microvascular Invasion in Hepatocellular Carcinoma , 2010, Cancer investigation.
[35] J. Llovet,et al. A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. , 2009, Gastroenterology.
[36] M. Sherman. Recurrence of hepatocellular carcinoma. , 2008, The New England journal of medicine.
[37] G. Raj,et al. How to build and interpret a nomogram for cancer prognosis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] Y. N. Park,et al. Prediction of microvascular invasion before curative resection of hepatocellular carcinoma , 2008, Journal of surgical oncology.
[39] Timothy M Pawlik,et al. Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[40] M. Makuuchi,et al. Risk factors of post-operative recurrence and adequate surgical approach to improve long-term outcomes of hepatocellular carcinoma. , 2013, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[41] L. Mariani,et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. , 2009, The Lancet. Oncology.